Boo-Hyon Kang Selected Research

GW 7647

1/2021	Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice.
1/2021	Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARα Agonist in PPARA-Humanized Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boo-Hyon Kang Research Topics

Disease

5	Necrosis 01/2021 - 07/2009
5	Neoplasms (Cancer) 01/2017 - 12/2010
4	Carcinogenesis 01/2017 - 12/2010
3	Hepatomegaly 01/2021 - 07/2009
2	Body Weight (Weight, Body) 01/2022 - 09/2011
2	Inflammation (Inflammations) 01/2016 - 11/2015
1	Hyperplasia 01/2022
1	Skin Neoplasms (Skin Cancer) 10/2017
1	Melanoma (Melanoma, Malignant) 10/2017
1	Neuroblastoma 01/2017
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Hepatitis B 01/2016
1	Atopic Dermatitis (Atopic Eczema) 01/2016
1	Breast Neoplasms (Breast Cancer) 04/2014
1	Diabetes Mellitus 12/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2013
1	Carcinoma (Carcinomatosis) 03/2013
1	Non-alcoholic Fatty Liver Disease 12/2011
1	Liver Diseases (Liver Disease) 12/2011
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2011
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2011
1	Chronic Hepatitis C 12/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2011
1	Body Weight Changes 09/2011
1	Hypertrophy 07/2009

Drug/Important Bio-Agent (IBA)

6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017 - 12/2010
5	LigandsIBA 10/2017 - 12/2010
2	GW 7647IBA 01/2021 - 01/2021
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2014 - 07/2009
1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2017
1	Dinitrochlorobenzene (DNCB)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Transcription Factor 3IBA 11/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2015
1	LipidsIBA 11/2015
1	Estrogen ReceptorsIBA 04/2014
1	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 12/2013
1	PowdersIBA 12/2013
1	Glycoside Hydrolases (Endoglycosidases)IBA 12/2013
1	Mucin-1 (CA 15-3 Antigen)IBA 03/2013
1	Capsules (Microcapsules)IBA 03/2013
1	CalponinsIBA 03/2013
1	VimentinIBA 03/2013
1	Phenobarbital (Luminal)FDA Link 03/2013
1	Keratins (Keratin)IBA 03/2013
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2011
1	Alanine Transaminase (SGPT)IBA 12/2011
1	IronIBA 12/2011
1	3-nitrotyrosineIBA 12/2011
1	Silk FDA Link 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2010
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 12/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2010
1	anthraceneIBA 12/2010
1	nimesulide (Aulin)IBA 12/2010
1	PPAR alphaIBA 07/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2009

Therapy/Procedure

2	Chemoprevention 10/2017 - 12/2010
1	Oral Administration 01/2022